No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Awakn Partners With University Of Nottingham For Preclinical Testing Of Psychoactive Therapy
Investors Back Awakn's Psychedelic Therapies, As Company Doubles Private Placement To $2M
CSE Bulletin: Reinstatement - Awakn Life Sciences Corp. (AWKN)
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
Awakn Life Sciences Inks Licensing Partnership Deal With Oklahoma-based Clinic
Canadian Securities Exchange Reports February 2024 Performance Figures
Unlock the Full List